Virinchi to acquire Bristlecone Hospitals business for Rs 100 Cr

Listed Co AcquisitionStrategic Transactions View source PDF Explain this filing

VIRINCHI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.9%Reaction day

₹15.40

prior close

₹15.50

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.4%+3.6% vs market

Software Products peers, median of 36sector+0.9%+4.1% vs sector

On the reaction day the stock moved 3.6 pts more than Nifty Microcap 250 and 4.1 pts more than its Software Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+3.8

10m

+3.8

15m

+2.9

30m

+1.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.9+1.4+3.6+0.9+4.1

Next day

+3.9+1.5+2.4+0.6+3.3

+3.2+0.5+2.7+0.2+3.0

+1.6+1.1+0.4+0.5+1.1

+0.1+0.7-0.5-0.3+0.4

+0.6-0.4+1.1-2.2+2.8

+2.5+0.5+1.9-2.3+4.8

15d

-0.1+0.1-0.1-2.8+2.7

+1.3+3.5-2.2-4.0+5.3

-7.7+5.8-13.5-3.7-4.0

-15.6+2.4-18.0-1.5-14.0

UpDownMarket · Nifty Microcap 250Sector · Software Products peers, median of 36Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Virinchi's board approved acquiring the Bristlecone Hospitals Primary and Secondary healthcare business from its material subsidiary VHCPL for Rs 100 Cr on a slump-sale basis, effective April 1, 2026. It is a related party transaction at arm's length, needing shareholder and other approvals. No shares will be issued; existing loans to VHCPL will be adjusted against the consideration. VHCPL's turnover was Rs 133.15 Cr in the most recent year. The move aims to build an AI-first healthcare platform while letting Virinchi Hospitals focus on tertiary and quaternary care.

Likely market impact

Internal restructuring - listed entity absorbing subsidiary's healthcare business. Watch shareholder vote outcome. No share dilution.